Revvity, Inc. today announced the development of the T-SPOTâ„¢ A201, a next-generation high-throughput automated platform ...
MarketsandMarketsâ„¢ projects the global high-throughput screening (HTS) market will grow from USD 27.66 billion in 2026 to USD ...
Molecular Devices developed an end-to-end, automated workflow, beginning with assay-ready colorectal cancer organoids, comprising establishment in culture, maintenance, and screening. Automation ...
Discover how the next generation of DMTA is creating a future-ready drug discovery engine through AI and automation.
High-throughput screening (HTS) is a cornerstone of modern drug discovery, enabling the evaluation of thousands to millions of potential drug compounds. Advances in automation and miniaturization have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results